Short survey: What matters most when choosing a development partner?

A Bionow member is conducting a short anonymous survey to explore how biotech and pharmaceutical companies source and evaluate external development partners throughout the drug development journey.

The findings will contribute to a broader understanding of current industry priorities, challenges and decision-making criteria. 

Individual responses will remain anonymous and results will be analysed and reported only at an aggregated level.

The survey takes 2-3 minutes to complete.

Survey: What matters most when choosing a development partner?